Building Scalable AI Tools for Financial Market Forecasting ✌️【References】✌️Start your investment journey with ₹500. Watch your returns multiply monthly! Building Scalable AI Tools for Financial Market Forecasting - Secure High-Yield Returns Today ✌️【References】✌️Turn ₹500 into massive returns with smart, high-yield investments!

Building Scalable AI Tools for Financial Market Forecasting ✌️【References】✌️Start your investment journey with ₹500. Watch your returns multiply monthly!Hamps Bio, a pharmaceutical products supplier, which ran its IPO from December 13 to December 17 made its debut on the BSE SME platform on Friday (December 20) listing at Rs 96.90 over the issue price of Rs 51.

Building Scalable AI Tools for Financial Market Forecasting ✌️【References】✌️Start investing with ₹500 and see your wealth grow rapidly every month.The shares of the company debuted at a premium of 90 per cent on the BSE SME platform.Hours before the official listing of the company on the Indian bourses, the GMP of Hamps BioIPOwas trading at Rs 60, with an estimated listing of Rs 111 per share, marking a 117.65 per cent gain in the greymarket, an unofficial marketplace to trade shares.The SME public issue, garnered a 1,057 times subscription.

Building Scalable AI Tools for Financial Market Forecasting ✌️【References】✌️Invest ₹500 and enjoy high monthly returns. Safe and reliable platform!The retail category lead the charge, with subscriptions soaring 1,342.04 times, while non-institutional investors (NII) subscribed 758.27 times.Also Read:DAM Capital Advisors IPO 2024 Live Updates: Check IPO price band, subscription status, GMP price, and other detailsHamps Bio IPO consisted entirely of a fresh issue of 12.2 lakh shares, with an aim of raising Rs 6.Building Scalable AI Tools for Financial Market Forecasting Smart Fund Investments for Steady Growth